1. Home
  2. VATE vs AFMD Comparison

VATE vs AFMD Comparison

Compare VATE & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • AFMD
  • Stock Information
  • Founded
  • VATE 1994
  • AFMD 2000
  • Country
  • VATE United States
  • AFMD Germany
  • Employees
  • VATE 4024
  • AFMD N/A
  • Industry
  • VATE Metal Fabrications
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • AFMD Health Care
  • Exchange
  • VATE Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • VATE 82.6M
  • AFMD 53.3M
  • IPO Year
  • VATE 1996
  • AFMD 2014
  • Fundamental
  • Price
  • VATE $6.10
  • AFMD $3.36
  • Analyst Decision
  • VATE
  • AFMD Strong Buy
  • Analyst Count
  • VATE 0
  • AFMD 5
  • Target Price
  • VATE N/A
  • AFMD $16.25
  • AVG Volume (30 Days)
  • VATE 50.3K
  • AFMD 80.0K
  • Earning Date
  • VATE 11-06-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • VATE N/A
  • AFMD N/A
  • EPS Growth
  • VATE N/A
  • AFMD N/A
  • EPS
  • VATE N/A
  • AFMD N/A
  • Revenue
  • VATE $1,364,600,000.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • VATE N/A
  • AFMD N/A
  • Revenue Next Year
  • VATE N/A
  • AFMD $48.98
  • P/E Ratio
  • VATE N/A
  • AFMD N/A
  • Revenue Growth
  • VATE N/A
  • AFMD N/A
  • 52 Week Low
  • VATE $3.25
  • AFMD $2.92
  • 52 Week High
  • VATE $14.60
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • VATE 71.67
  • AFMD 44.84
  • Support Level
  • VATE $6.18
  • AFMD $3.28
  • Resistance Level
  • VATE $6.49
  • AFMD $3.51
  • Average True Range (ATR)
  • VATE 0.43
  • AFMD 0.17
  • MACD
  • VATE 0.05
  • AFMD 0.04
  • Stochastic Oscillator
  • VATE 86.72
  • AFMD 55.79

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: